Analysis Intellipharmaceutics International Inc. (IPCIF)
6/2/2024
Analysis of Intellipharmaceutics International Inc. (IPCIF)
Intellipharmaceutics International Inc. (IPCIF) is currently trading at a price of 0.06000. The Relative Strength Index (RSI) indicator is at 49.36, indicating a neutral position. The Moving Average Convergence Divergence (MACD) indicator is slightly negative at -0.00421, with the signal line at -0.00322.Looking at the recent price movements, on May 31, the stock opened at 0.10000 and closed at 0.02000, with an RSI of 38.54 and a MACD of -0.00472. The Moving Average (MA) indicator is at 0.06360, with the Simple Moving Average (SMA) at the same level.
Overall, the stock has shown some volatility in recent days, with fluctuations in price and mixed signals from technical indicators. Traders and investors may want to closely monitor the stock for further developments before making any trading decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The company's financials show a strong cash flow, with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet indicates a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31%, with a return on assets of 22.07% and return on equity of 147.25%. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a net income to common of $100.39 billion. The company's operating margin is 30.74%, with a revenue per share of $24.54.In terms of stock statistics, the company has a short ratio of 1.53, with 99.29 million shares shorted out of 15.31 billion float shares. The stock has a market capitalization of $2.92 trillion, with a PEG ratio of 26.32 and a forward P/E ratio of 26.32. The stock price summary shows a beta of 1.26, with a 50-day moving average of $176.26 and a 200-day moving average of $181.04. The stock's 52-week low is $164.08 and the high is $199.62.
Regarding dividends and splits, the company has a payout ratio of 14.93% and a forward annual dividend rate of $1, with a trailing annual dividend yield of 0.51%. The last split date was on August 31, 2020, with a 4-for-1 split factor. The 5-year average dividend yield is 0.73%.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, showing a sales growth of 3% compared to the previous year's same quarter. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, showing a significant sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are forecasting moderate to strong sales growth for both the upcoming quarters and the next fiscal year, indicating positive expectations for the company's performance in the near future.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest a positive growth trend for the company, with a slight increase in growth rate expected in the coming years compared to the current period. However, the growth rate is projected to be lower than the average growth rate observed in the past 5 years.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median and average price above the current price. However, there is a wide range between the low and high forecasts, indicating some uncertainty or differing opinions among analysts.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales have been increasing steadily over the past four fiscal years.
2. The EBIT (Earnings Before Interest and Taxes) and EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) have also shown a positive trend, indicating improving operational efficiency.
3. The net income has been growing consistently, reflecting the company's profitability.
4. The basic and diluted earnings per share (EPS) have been relatively stable over the years.
5. The company has been effectively managing its cost of goods sold and operating expenses to maintain profitability.
6. The company has been able to generate a healthy gross profit margin.
7. The non-operating interest expenses have been relatively stable, indicating a consistent financial strategy.
8. The company has been able to maintain a stable number of basic and diluted shares outstanding.
9. Overall, the financial performance of the company seems to be positive and improving over the years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown a positive trend, indicating a healthy financial position.
6. The company has been investing in leases, land, and improvements, reflecting a focus on long-term growth.
7. There is a consistent level of short-term debt and accounts payable, with variations in other current liabilities.
8. Retained earnings have fluctuated over the years, impacting the overall shareholders' equity.
9. The company has been managing risks and charges through provisions in non-current liabilities.
10. Overall, the financial stability and growth of the company seem to be well-maintained based on the balance sheet data.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant variability, with large amounts being spent on common stock repurchase and debt issuance and payments.
6. Investing activities also vary, with notable amounts spent on the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company's financial performance seems to be stable, with some fluctuations in key financial metrics over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average EPS is projected to be $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, analysts forecast an average EPS of $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates indicate a positive outlook for the company's earnings per share, with expected growth in both the quarterly and annual results over the specified periods.
MACD of IPCIF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
